Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xingshen Huayu Dripping Pills
- Development stage
- Unknown
- Lead developer
- Yabao Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Xingshen Huayu Dripping Pills is a Traditional Chinese Medicine (TCM) formulation developed by the Beijing University of Chinese Medicine Pharmaceutical Factory for the treatment of acute cerebral infarction (ischemic stroke). The drug is designed according to the TCM principles of awakening the spirit (Xingshen) and resolving blood stasis (Huayu). Its primary active ingredients are derived from medicinal herbs including *Panax notoginseng* (Sanqi), *Borneolum Syntheticum* (Bingpian), and *Acorus tatarinowii* (Shichangpu). The formulation aims to improve neurological deficits, reduce the volume of cerebral infarction, and protect neurons from ischemic injury. Pharmacologically, it has been shown to improve cerebral microcirculation, inhibit platelet aggregation, and modulate the permeability of the blood-brain barrier, thereby facilitating the delivery of therapeutic components to the brain. It has completed Phase III clinical trials in China, demonstrating efficacy in improving neurological function scores in patients with acute ischemic stroke.
- Brand names
- Xingshen Huayu Dripping Pills
- Other names
- Xingshen Huayu Diwan醒神化瘀滴丸
02
Targets
GABRA1 (Gamma-aminobutyric acid type A receptor alpha 1 subunit)CASP3 (Caspase-3)P2Y12 (Purinergic P2Y12 receptor)
Beyond the preview
Go deeper on Xingshen Huayu Dripping Pills.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xingshen Huayu Dripping Pills.